Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SNOA vs FEED: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SNOA Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

SNOA Overall Winner 6-Pillar Tally: SNOA 5 – 0 FEED (1 Tie) Matrix Metrics: SNOA 8 – 2 FEED

As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNOA carries a Unified Composite Score of 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin), whereas FEED carries 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY).
  • Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both SNOA (36.4/100 SELL) and FEED (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: SNOA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1); meanwhile FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SNOA vs FEED
SNOA NASDAQ Head-to-Head Winner
Sonoma Pharmaceuticals, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.72
-10.83% 1D
Market Cap $4.1M
TTM Revenue $23M
Forward P/E 46.1x
Beta / 30D Vol 1.59β · 92% Vol
Unified Composite Score
36.4 / 100 SELL
Tech 25.0 Fund 37.0 Flow 50.0 Mom 34.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 24
RSI-14: 24.1 · SMA20: $1.05 · SMA50: $1.15
FEED US Equity
FEED
Institutional Equity
$1.03
-69.25% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -6.40β · 3942% Vol
Unified Composite Score
37.1 / 100 SELL
Tech 15.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.1 · SMA20: $1.98 · SMA50: $1.04

6-Pillar Scorecard Institutional Category Breakdown (SNOA 5 – 0 FEED)

Columns: Metric · SNOA · FEED
1. Valuation Multiples SNOA
Forward P/E 46.1x N/M
Trailing P/E 46.1x N/M
PEG Ratio 1.08x N/M
EV / Revenue 0.1x N/M
2. Growth & Scale SNOA
Revenue Growth (YoY) +28.0% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $23M N/A
Market Cap $4.1M N/A
3. Profitability & Quality SNOA
Gross Margin 39.2% N/A
Operating Margin -3.3% N/A
Net Profit Margin -7.6% N/A
Return on Equity (ROE) -34.5% N/A
4. Balance Sheet & Cash Flow SNOA
Cash Generation (TTM) -$4.1M N/A
Cash Flow Margin -17.6% N/A
Net Cash / Leverage $1.6M Net Cash N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat SNOA
OpEx & R&D Intensity 42.5% of Rev ($10.0M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SNOA (8) vs FEED (2)
Institutional Metric SNOA FEED Criterion Row Edge
Market Capitalization
Scale
$4.1M N/A Larger Scale SNOA
Trailing P/E Ratio
Valuation
46.1x N/M Lower Multiple SNOA
Forward P/E Ratio
Valuation
46.1x N/M Lower Multiple SNOA
Revenue Growth (YoY)
Growth
+28.0% N/A Higher Growth SNOA
Operating Margin (TTM)
Profitability
-3.3% N/A Higher Margin SNOA
Net Profit Margin
Profitability
-7.6% N/A Higher Margin SNOA
Return on Equity (ROE)
Capital Efficiency
-34.5% N/A Higher ROE SNOA
52-Week Range Position
Momentum
0% ($1–$4) 13% ($0–$6) Stronger Trend FEED
Beta / 30D Volatility
Risk Regime
1.59β · 92% Vol -6.40β · 3942% Vol Lower Realized Risk SNOA
Unified Institutional Score
Composite Signal
36.4 / 100 (SELL) 37.1 / 100 (SELL) Higher Composite FEED
Trailing 12M Revenue (USD)
Operating Scale
$23M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
39.2% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.08x PEG · 0.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.1M ($1.6M Net Cash) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FEED +137.24 pp
SNOA: -1.54% · FEED: +135.7%
3M Horizon FEED +13.43 pp
SNOA: +15.32% · FEED: +28.75%
6M Horizon FEED +3.17 pp
SNOA: -46.89% · FEED: -43.72%
1Y Horizon SNOA +10.53 pp
SNOA: -64.74% · FEED: -75.27%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNOA vs FEED. Trailing 12-month operating profitability (SNOA -3.3% vs FEED N/A) and valuation multiples (SNOA 46.1x vs FEED N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SNOA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$23M
Gross Margin39.2%
Op. Margin-3.3%
ROE / Fwd P/E-34.5% · 46.1x
FEED ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SNOA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNOA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FEED UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FEED Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SNOA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $4.1M market capitalization and -3.3% operating margin.
OpEx & R&D Reinvestment 42.5% of Rev ($10.0M)
90D Engineering Disclosures 0 Published
FEED Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SNOA vs FEED Key Questions & Quantitative Answers

As of Nov 20, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) is the stronger overall head-to-head candidate over FEED (FEED) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNOA carries a Unified Composite Score of 36.4/100 (SELL) at $0.72 (46.1x Forward P/E, -3.3% operating margin), whereas FEED carries 37.1/100 (SELL) at $1.03 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While FEED currently prints a higher short-term Unified Composite Score (37.1/100 SELL vs. SNOA 36.4/100 SELL), SNOA captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-3.3% vs. N/A operating margin) and revenue trajectory (+28.0% vs. N/A YoY). Defensive Composite Rating Caution: Although SNOA compares more favorably head-to-head, both SNOA (36.4/100 SELL) and FEED (37.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: SNOA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1); meanwhile FEED trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SNOA leads the Growth & Scale pillar: SNOA posts +28.0% YoY revenue growth and +0.0% YoY earnings growth on $23M TTM revenue (39.2% gross margin, -3.3% operating margin), compared with FEED at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SNOA generates $23M in USD-normalized revenue versus N/A for FEED. In operating R&D and SG&A reinvestment, SNOA deploys 42.5% of Rev ($10.0M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FEED.

SNOA screens cheaper on headline valuation multiples. SNOA trades at 46.1x Forward P/E, 46.1x Trailing P/E, 1.08x PEG, and 0.1x EV/Revenue (-17.6% FCF margin), whereas FEED trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNOA (-34.5% ROE) versus FEED (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, SNOA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.59β · 92% Vol realized risk). By comparison, FEED carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.40β · 3942% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.